Art

J-GLOBAL ID：201702290041604834   Reference number：17A0086623

Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging

ハイブリド蛋白質-無機ナノ粒子:腫瘍標的化薬剤デリバリーから癌造影まで

Author (5)： Elzoghby Ahmed O. (Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt) ,  Elzoghby Ahmed O. (Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt) ,  Hemasa Ayman L. (Department of Pharmacy, School of Medicine, Faculty of Health, University of Tasmania, Hobart, Tasmania, Australia) ,  Freag May S. (Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt) ,  Freag May S. (Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt)
Material： Journal of Controlled Release  (J Control Release)
Volume： 243  Page： 303-322  Publication year： Dec. 10, 2016 
JST Material Number： C0308D  ISSN： 0168-3659  Document type： Article
Article type： 文献レビュー  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *nanocomposites ,...
Semi thesaurus term： *composite nanoparticle ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0086623&from=J-GLOBAL&jstjournalNo=C0308D") }}

Author keywords (7)： Nanohybrids ,  Protein nanoparticles ,  Inorganic nanoparticles ,  Tumor targeting ,  Anti-cancer drug delivery ,  Cancer imaging ,  Theranostics

JST classification (3)： Basic biopharmacy  (GY01021U) ,  Medical materials  (GA05040H) ,  Basic diagnostics  (GC03002P)

Reference (143)：

• N. Bertrand, J. Wu, X. Xu, N. Kamaly, O.C. Farokhzad, Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology, Adv. Drug Deliv. Rev. 66 (2014) 2-25.
• A.O. Elzoghby, M.W. Helmy, W.M. Samy, N.A. Elgindy, Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model, Pharm. Res. 30 (2013) 2654-2663.
• A.O. Elzoghby, N.I. Saad, M.W. Helmy, W.M. Samy, N.A. Elgindy, lonically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats, Eur. J. Pharm. Biopharm. 85 (2013) 444-451.
• J. Nam, N. Won, J. Bang, H. Jin, J. Park, S. Jung, S. Jung, Y. Park, S. Kim, Surface engineering of inorganic nanoparticles for imaging and therapy, Adv. Drug Deliv. Rev. 65 (2013) 622-648.
• E.C. Cho, C. Glaus, J. Chen, MJ. Welch, Y. Xia, Inorganic nanoparticle-based contrast agents for molecular imaging, Trends Mol. Med. 16 (2010) 561-573.

Terms in the title (7)： 蛋白質 ,  ナノ粒子 ,  腫瘍標的化 ,  薬剤 ,  デリバリー ,  癌 ,  造影